drugset / Trial / NCT03088852

Magnesium Deficiency In Patients Hospitalized in Internal Medicine Wards

NCT03088852

Phase 4 Recruiting 330 enrolled Frieda Wolf
RandomizedParallel-groupOpen-labelTreatment

Summary

Hypomagnesemia is a common entity in the inpatient and outpatient setting. in previous retrospective study hypomagnesemic patients have higher mortality and longer hospitalization. whether hypomagnesemia is merely a marker of poor prognosis, or whether replacing it can improve outcomes is unclear. The current standard of care is to discharge these patients without workup or further treatment, even if patients had received intravenous therapy while hospitalized. The investigator wish to examine prospectively whether giving replacement therapy affects mortality, length of hospital stay and overall well-being. In order to replete intracellular levels and replete magnesium stores, magnesium should be given for several months.

Timeline

Start
2017-05-10
Primary completion
2025-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Citrate Unknown 400 mg Oral

Indications